Leveraging AI for protein fitness optimization
AI has emerged as a transformative force in solving complex biological challenges in the era of data-driven innovation. At the intersection of […]
Covalent binder design with Gen AI & FBDD
Covalent small molecule drugs are highly valued for their ability to precisely inhibit challenging “hard-to-drug” proteins by forming stable, irreversible bonds with […]
De Novo PROTAC Design with Gen AI and FBDD
A PROTAC (PROteolysis TArgeting Chimera) is a small molecule that facilitates the degradation of disease-causing proteins by recruiting an E3 ubiquitin ligase […]
Target elucidation: Key first steps for structure based in silico drug design
BioPharma wins come after long and hard fought battles. Every phase of a drug discovery battle poses its own challenges. Deep Science and Deep Tech innovations are continuously expanding the options available for addressing these challenges.
Industry-Academia collaborations to design next generation anti-malaria drugs
Partnership between academic research institutions and the biopharma industry has been essential for making breakthrough discoveries in disease research and translating those discoveries into therapies available in the clinic.
Rare Disease Day, 2024
Rare diseases affect a staggering 300 million people worldwide. Often genetic in origin, rare diseases demand our attention and support for research. On Rare Disease Day, we highlight the challenges faced by these individuals and the urgent need for solutions.
Accelerating Discovery: High-Throughput Science for Data & Computer Scientists
How High-throughput science is providing value creation opportunities for Data and Computer Scientists. The digital transformation journey has been exhilarating, spurred by the Internet and smartphones. Big data and AI advancements have now birthed modern data science, transforming every field.